Vietnam Over The Counter (OTC) Drugs Market, By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027

Abstract
Vietnam over the counter (OTC) drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of expanding pharmaceutical industry of the country. Vietnam's healthcare industry does not have the capable resources for consistent research and advancement in drug designing, pharmacy advancement, etc. Therefore, the local pharmaceutical manufacturers and contract manufacturing organizations are solely invested in the manufacturing of generics, biosimilars, and over-the-counter (OTC) drugs, thus driving the growth of Vietnam over the counter (OTC) drugs market in the upcoming five years.
Over-the-counter, (OTC) drugs are non-prescription-based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without a physician's prescription. Although, as a general awareness physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over-the-counter (OTC) drugs.
Expanding Pharmaceutical Industry Satisfies Demand
Demand for counter (OTC) drugs is expediting due to rapid demands from the common population of the country. Although, due to the increasing population that can spend more on branded drugs and new advanced medicine, still a large portion of the total population, exceeding 98 million population is inclined toward generic drugs, OTC drugs, and biosimilars. The growing pharmaceutical industry is also stabilized due to the consistent flow of investments in the form of government financial assistance.
In the year, 2018 Vietnam's pharmaceutical industry was valued at USD5.34 billion. The industrial production index in the year exceeded 121.8 in the year 2020, demonstrating higher production and manufacturing of pharmaceutical products like OTC drugs, thus substantiating the growth of the Vietnam OTC drugs market in the future five years.
Market Segmentation
The Vietnam over-the-counter (OTC) drugs market is segmented by product, route of administration, dosage forms, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into a cough, cold, and flu; vitamins, minerals, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. The market is also fragmented based on the route of administration of the drugs into oral, topical, and parenteral. Based on dosage form, the market is bifurcated into tablets, capsules, liquids & solutions, creams/ lotions/ ointments, and others. By distribution channel, the market is differentiated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Northern region, Central region, and the Southern region.
Company Profile
Sanofi-Aventis Vietnam Company, GlaxoSmithKline Vietnam, Reckitt Benckiser Vietnam, Imexpharm Pharmaceutical Joint Stock Company, DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, Vimedimex Medi-Pharma Joint Stock Company, Vietnam Pharmaceutical Corporation, Ha Tay Pharmaceutical Joint Stock Company, among others is a partial list of major market players of the companies responsible for the growth of Vietnam over the counter (OTC) drugs market.


Report Scope:
In this report, Vietnam over the counter (OTC) drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
•Vietnam Over The Counter (OTC) Drugs Market, By Product:
oCough, Cold, and Flu
oVitamins, Mineral, and Supplements (VMS)
oAnalgesics
oGastrointestinal Products
oDermatology Products
oOthers
•Vietnam Over The Counter (OTC) Drugs Market, By Route of Administration:
oOral
oTopical
oParenteral
•Vietnam Over the counter (OTC) drugs Market, By Dosage Form:
oTablets
oCapsules
oLiquids & Solution
oCreams/Lotions/Ointments
oOthers
•Vietnam Over The Counter (OTC) Drugs Market, By Distribution Channel:
oRetail Pharmacy
oHospital Pharmacy
oE-Pharmacy
•Vietnam Over The Counter (OTC) Drugs Market, By Region:
oNorthern Region
oCentral Region
oSouthern Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Vietnam over the counter (OTC) drugs market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).

Content
Table of Contents

1.Product Overview
2.Research Methodology
3.Impact of COVID-19 on Vietnam Over the counter (OTC) drugs (OTC) Drugs Market
4.Executive Summary
5.Voice of Customers
6.Vietnam Over the counter (OTC) drugs (OTC) Drugs Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2.By Route of Administration (Oral, Topical, Parenteral)
6.2.3.By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4.By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5.By Region
6.2.6.By Company (2021)
6.3.Product Market Map
7.Vietnam Cough, Cold and Flu Over the counter (OTC) drugs (OTC) Drugs Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Route of Administration
7.2.2.By Dosage Form
7.2.3.By Distribution Channel
8.Vietnam Vitamins, Mineral and Supplements (VMS) Over the counter (OTC) drugs (OTC) Drugs Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Route of Administration
8.2.2.By Dosage Form
8.2.3.By Distribution Channel
9.Vietnam Analgesics Over the counter (OTC) drugs (OTC) Drugs Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Route of Administration
9.2.2.By Dosage Form
9.2.3.By Distribution Channel
10.Vietnam Gastrointestinal Over the counter (OTC) drugs (OTC) Drugs Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Route of Administration
10.2.2.By Dosage Form
10.2.3.By Distribution Channel
11.Vietnam Dermatology Over the counter (OTC) drugs (OTC) Drugs Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Route of Administration
11.2.2.By Dosage Form
11.2.3.By Distribution Channel
12.Market Dynamics
12.1.Drivers
12.2.Challenges
13.Market Trends & Developments
14.Policy & Regulatory Landscape
15.Vietnam Economic Profile
16.Competitive Landscape
16.1.Competition Outlook
16.2.Company Profiles
16.2.1.Sanofi-Aventis Vietnam Company
16.2.2.GlaxoSmithKline Vietnam
16.2.3.Reckitt Benckiser Vietnam
16.2.4.Imexpharm Pharmaceutical Joint Stock Company
16.2.5.DHG Pharmaceutical Joint Stock Company
16.2.6.Traphaco Joint Stock Company
16.2.7.Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company
16.2.8.Vimedimex Medi-Pharma Joint Stock Company
16.2.9.Vietnam Pharmaceutical Corporation
16.2.10.Ha Tay Pharmaceutical Joint Stock Company
17.Strategic Recommendations